Earnings History Data for Rani Therapeutics Holdings, Inc. (RANI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings Inc. is a clinical stage biotherapeutics company. It focused on advancing technologies to enable the development of orally administered biologics. Rani Therapeutics Holdings Inc. is based in SAN JOSE, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
20-03-2024	AH		RANI	Rani Therapeutics Holdings, Inc.	166.99	-0.27	-0.31	-0.35	Rani Therapeutics GAAP EPS of -$0.27 beats by $0.04 [3/20/2024 4:17 PM]	3.50	-0.07 (-1.96%)	3.43	-0.14 (-3.92%)	1.82 - 6.23	63,240	80,000	2,610
Rani Therapeutics GAAP EPS of -$0.27 beats by $0.04 [3/20/2024 4:17 PM]
11-08-2023	AH		RANI	Rani Therapeutics	218.00	-0.37	-0.40	0.00	Rani Therapeutics GAAP EPS of -$0.37 beats by $0.04 [8/11/2023 4:23 PM]	4.29	0.09 (2.14%)	4.24	0.04 (0.95%)	3.65 - 12.24	42,573	40,000	2,119

22-03-2023	AH	4:05 PM ET (Mar 22)	RANI	Rani Therapeutics Holdings, Inc.	314.38	-0.35	-0.25	-0.27	Rani Therapeutics GAAP EPS of -$0.35 in-line [3/22/2023 4:23 PM]	5.59	-0.36 (-6.05%)	0.0	0.0 (0.00%)	4.92 - 14.90	33,750	20,000	0
Rani Therapeutics GAAP EPS of -$0.35 in-line [3/22/2023 4:23 PM]
10-11-2022	AH		RANI	Rani Therapeutics	320.00	-0.33	-0.33	0.00	Rani Therapeutics GAAP EPS of -$0.33 [11/10/2022 11:00 PM]	6.54	0.19 (2.91%)	0.0	0.0 (0.00%)	5.62 - 36.27	18,159	40,000	0
Rani Therapeutics GAAP EPS of -$0.33 [11/10/2022 11:00 PM] Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates [Nov-10-22 05:25PM] Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-10-22 04:05PM]
10-08-2022	AH	4:05 PM ET (Aug 10)	RANI	Rani Therapeutics	590.00	-0.31	-0.28	0.00	Rani Therapeutics GAAP EPS of -$0.31 beats by $0.06 [8/10/2022 5:48 PM]	3.76	-0.21 (-5.29%)	10.75	-0.35 (-3.20%)	3.68 - 12.42	14,481	20,000	1,876
Rani Therapeutics GAAP EPS of -$0.31 beats by $0.06 [8/10/2022 5:48 PM] Rani Therapeutics' hormone drug RT-102 for osteoporosis well-tolerated in phase 1 study [8/10/2022 6:12 PM] Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock [Aug-10-22 05:28PM] Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update [Aug-10-22 04:28PM] Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis [Aug-10-22 04:23PM]
11-05-2022	AH	4:05 PM ET (May 11)	RANI	Rani Therapeutics	520.00	-0.29	-1.00	0.00	Rani Therapeutics GAAP EPS of -$0.29 beats by $0.03 [5/11/2022 4:47 PM]	9.97	-0.63 (-5.94%)	0.0	0.0 (0.00%)	9.24 - 36.27	34,889	40,000	0
Rani Therapeutics GAAP EPS of -$0.29 beats by $0.03 [5/11/2022 4:47 PM] Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update [May-11-22 04:05PM]
29-03-2022	AH	7:30 PM ET (Mar 29)	RANI	Rani Therapeutics Holdings, Inc.	274.43	-0.27	-1.28	0.00	Rani Therapeutics GAAP EPS of -$0.27 misses by $0.04 [3/29/2022 4:19 PM]	13.60	-0.42 (-3.03%)	14.72	0.70 (4.99%)	9.24 - 36.27	17,539	30,000	450
Rani Therapeutics GAAP EPS of -$0.27 misses by $0.04 [3/29/2022 4:19 PM] Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update [Mar-29-22 04:05PM]
15-11-2021	PM		RANI	Rani Therapeutics	1,400	-0.16	-0.21	0.00	Rani Therapeutics EPS beats by $0.02 [11/16/2021 5:26 AM]	30.87	0.77 (2.56%)	29.50	-0.60 (-1.99%)	9.24 - 34.99	32,224	80,000	1,271
Rani Therapeutics EPS beats by $0.02 [11/16/2021 5:26 AM] Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update [Nov-15-21 07:31PM] Rani Therapeutics Appoints Lyn Baranowski to Board of Directors [Nov-12-21 04:05PM]